Similac Advance
This article was originally published in The Tan Sheet
Executive Summary
Ross Products' DHA-, ARA-fortified infant formula will be marketed under Martek Bioscience's GRAS affirmation, granted in May, for algae-derived fatty acids, both companies confirmed. Abbott Labs division's own GRAS petition for tuna-derived DHA, filed Jan. 2, is still pending at FDA, contrary to a report in 1"The Tan Sheet" Feb. 25, 2002, In Brief...
You may also be interested in...
Similac Advance
Ross Products' infant formula fortified with Martek Biosciences' DHA, ARA fatty acid oils will be available by mid-April in food, drug, mass stores, Abbott Labs division says. Advance will come in 12.9 oz. and 25.7 oz. powder, 32 oz. ready-to-feed plastic bottle; formula will be priced at 15% premium over existing products. Ross says it has received FDA clearance for its GRAS petition, submitted Jan. 2; firm will be second to market fortified formula in the U.S. following Mead Johnson's launch of Enfamil LIPIL, reaching shelves this month (1"The Tan Sheet" Jan. 14, 2002, p. 3)...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.